T5	Effect 13 22	hepatitis
T7	Treatment 56 129	combined treatment with pegvisomant and octreotide long-acting repeatable
T8	Subject 26 48	an acromegalic patient
T9	Treat-Disorder 29 40	acromegalic
T10	Drug 80 91	pegvisomant
T11	Drug 96 106	octreotide
T6	Adverse_event 5 12	induced
T12	Combination 92 95	and
E1	Adverse_event:T6 
E2	Combination:T12 arg:T10 arg2:T11
